Also Read
- Abcuro Secures $66M Series D to Advance Ulviprubart in Less Severe IBM Patients After Disappointing Phase 2/3 Results
- Hormone Therapy Is Still Not a Dementia Prevention Tool Under Current Guidance Despite New Autopsy Findings
- Study Reveals Widespread Undisclosed Toxic Chemicals in Everyday Personal Care Products
- Ancient Arctic Predator’s Crystal–clear Vision Holds Secrets to Centuries of Healthy Eyesight

